Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 110 Records) |
Query Trace: Lymphoma and KRAS[original query] |
---|
Quantitative features of dual-energy spectral computed tomography for solid lung adenocarcinoma with EGFR and KRAS mutations, and ALK rearrangement: a preliminary study. Translational lung cancer research 2019 9 8 (4): 401-412. Li Meng, Zhang Li, Tang Wei, Ma Pei-Qing, Zhou Li-Na, Jin Yu-Jing, Qi Lin-Lin, Wu Ni |
Activating Mutations in PTPN11 and KRAS in Canine Histiocytic Sarcomas. Genes 2019 7 10 (7): . Takada Marilia, Smyth Lauren A, Thaiwong Tuddow, Richter Marlee, Corner Sarah M, Schall Peter Z, Kiupel Matti, Yuzbasiyan-Gurkan Vil |
Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma. Cells 2019 May 8 (6): . Dhieb Dhoha, Belguith Imen, Capelli Laura, Chiadini Elisa, Canale Matteo, Bravaccini Sara, Yangui Ilhem, Boudawara Ons, Jlidi Rachid, Boudawara Tahya, Calistri Daniele, Keskes Leila Ammar, Ulivi Pao |
Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma. American journal of clinical oncology 2019 2 42 (4): 337-344. Gupta Rohan, Amanam Idoroenyi, Rahmanuddin Syed, Mambetsariev Isa, Wang Yingyu, Huang Charity, Reckamp Karen, Vora Lalit, Salgia Ra |
Genotyping and cytomorphological subtyping of lung adenocarcinoma based on liquid-based cytology. Diagnostic cytopathology 2019 Feb . Tanaka Ryota, Sakamoto Norihiko, Suzuki Hitomi, Tachibana Keisei, Ohtsuka Kouki, Kishimoto Koji, Fujiwara Masachika, Kamma Hiroshi, Shibahara Junji, Kondo Haruhi |
Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. Virchows Archiv : an international journal of pathology 2019 12 476 (4): 609-614. Péricart Sarah, Waysse Charlotte, Siegfried Aurore, Struski Stephanie, Delabesse Eric, Laurent Camille, Evrard Solè |
Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study. Thrombosis research 2019 Dec 186 36-41. Dou Feifei, Zhang Yuan, Yi Jiawen, Zhu Min, Zhang Shu, Zhang Di, Zhang Yuh |
Morphological characterization and molecular profiling of malignant pericardial effusion in patients with pulmonary adenocarcinoma. Indian journal of pathology & microbiology 0 62 (4): 566-571. Zhou Bing, Li Lin, Shi Dayou, Jiang Tao, Xue Guohui, Xiong Jianpi |
Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma. Journal of Cancer 2019 10 (1): 61-71. Li Pupu, Gao Qiongqiong, Jiang Xiangli, Zhan Zhongli, Yan Qingna, Li Zhaona, Huang Ch |
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2020 9 34 (2): 336-347. Egan Caoimhe, Lack Justin, Skarshaug Shannon, Pham Thu Anh, Abdullaev Zied, Xi Liqiang, Pack Svetlana, Pittaluga Stefania, Jaffe Elaine S, Raffeld Ma |
[Analysis of Clinical Characteristics and Driver Genes in 405 Patients with Lung Cancer Complicated with Tuberculosis]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 4 23 (5): 337-342. Hu Ying, Yang Xinjie, Nie Lihui, Zhao Dan, An Jun, Li Baol |
[Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 Apr 23 (4): 239-246. Liang Yu, Hou Helei, Jiang Man, Zhang Chuantao, Liu Dong, Zhang Xiaoch |
Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report. Thoracic cancer 2020 2 11 (4): 1094-1098. Tang Yong, Li Yadan, Zhang Lei, Tong Guihui, Ou Zhu'an, Wang Zhuocai, Zhang Henghui, Qiao Guib |
Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway. Blood cancer discovery 2020 11 1 (1): 112-125. Liu Zhaoqi, Filip Ioan, Gomez Karen, Engelbrecht Dewaldt, Meer Shabnum, Lalloo Pooja N, Patel Pareen, Perner Yvonne, Zhao Junfei, Wang Jiguang, Pasqualucci Laura, Rabadan Raul, Willem Pasca |
Characterization of CD66b and its relationship between immune checkpoints and their synergistic impact in the prognosis of surgically resected lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2021 9 160 84-91. Shen Mingjing, Jiang Kanqiu, Sui Yiqun, Xu Zhonghua, Cui Hongxia, Wang Youyou, Zhang Huan, Xu Zhonghen, Xu Weihua, Ding Qifeng, Chen Yongbi |
Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement. Cancer reports (Hoboken, N.J.) 2021 9 5 (7): e1545. Yoshida Masanori, Tomizawa Daisuke, Yoshimura Satoshi, Osumi Tomoo, Nakabayashi Kazuhiko, Ogata-Kawata Hiroko, Ishiwata Keisuke, Sato-Otsubo Aiko, Kimura Yui, Ito Shuichi, Matsumoto Kimikazu, Deguchi Takao, Kiyokawa Nobutaka, Yoshioka Takako, Hata Kenichiro, Kato Motohi |
Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces. Annals of translational medicine 2021 Jun 9 (12): 985. Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu |
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations. Cancer research and treatment 2021 5 54 (1): 30-39. Choi Yoon Ji, Choi Jung Yoon, Kim Ju Won, Lim Ah Reum, Lee Youngwoo, Chang Won Jin, Lee Soohyeon, Sung Jae Sook, Chung Hee-Joon, Lee Jong Won, Kang Eun Joo, Kim Jung Sun, Lim Taekyu, Kim Hye Sook, Kim Yu Jung, Ahn Mi Sun, Kim Young Saing, Park Ji Hyun, Lim Seungtaek, Cho Sung Shim, Cho Jang Ho, Shin Sang Won, Park Kyong Hwa, Kim Yeul Ho |
Profiling Oncogenic Germline Mutations in Unselected Chinese Lung Cancer Patients. Frontiers in oncology 2021 4 11 647598. Yang Jie, Li Hefei, Li Ben, Li Wei, Guo Qiang, Hu Ling, Song Zizheng, Zhou B |
Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib. Translational lung cancer research 2021 4 10 (3): 1525-1535. Li Jingjing, Zhang Bin, Zhang Yu, Xu Feng, Zhang Zhenfa, Shao Lin, Yan Chunhe, Ulivi Paola, Denis Marc G, Christopoulos Petros, Thomas de Montpréville Vincent, Bernicker Eric H, van der Wekken Anthonie J, Wang Changli, Yue Dongshe |
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data. Oncoimmunology 2021 2 10 (1): 1865653. Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair, |
Computed tomography-guided lung biopsy for molecular tests: a meta-analysis. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101. Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. Cancer research and treatment 2022 Mar . Kim Seok Jin, Kim Yeon Jeong, Yoon Sang Eun, Ryu Kyung Ju, Park Bon, Park Donghyun, Cho Duck, Kim Hyun-Young, Cho Junhun, Ko Young Hyeh, Park Woong-Yang, Kim Won Se |
Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib. Translational cancer research 2022 2 8 (4): 1630-1634. Zhu You-Cai, Wan Bing, Wu Li-Xin, Li Xing-Liang, Wang Wen-Xian, Xu Chun-Wei, Zhuang Wu, Wei Jian-Guo, Du Kai- |
Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments. Oncology letters 2022 Oct 24 (4): 362. Zhou Lin, Li Huiwu, Yang Shuh |
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial. Cancer 2022 Jun . Cortellini Alessio, Ricciuti Biagio, Borghaei Hossein, Naqash Abdul Rafeh, D'Alessio Antonio, Fulgenzi Claudia A M, Addeo Alfredo, Banna Giuseppe L, Pinato David Jam |
Genomic profiling of primary diffuse large B-cell lymphoma of the central nervous system suggests novel potential therapeutic targets. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 9 100323. Claudio Agostinelli, Luca Morandi, Simona Righi, Luigi Cirillo, Marica Iommi, Caterina Tonon, Diego Mazzatenta, Matteo Zoli, Maura Rossi, Gianmarco Bagnato, Alessandro Broccoli, Raffaele Lodi, Pier Luigi Zinzani, Elena Sabattini, Caterina Giannini, Sofia Asio |
The Prognostic and Functional Impact of Sprouty 2 Expression in Non-small Cell Lung Cancer. American journal of clinical oncology 2023 9 . Yusuf Acikgoz, Fatma Unal Yildirim, Selin Akturk Esen, Gokhan Ucar, Yakup Ergun, Oznur Bal, Mutlu Dogan, Dogan Un |
Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations. European journal of cancer (Oxford, England : 1990) 2023 3 184 172-178. Cortiula Francesco, De Ruysscher Dirk, Steens Michelle, Wijsman Robin, van der Wekken Anthonie, Alberti Martina, Hendriks Lizza E |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: